Location: Home
  • search
  • go
  • Relate News
  • 4/22/2025Zai Lab's Repotrectinib sNDA Accepted by China NMPA
  • 4/22/2025Ensem Thera Advances China-Linked Oncology Program with U.S. FDA IND C...
  • 4/22/2025Kelun-Biotech's ADC SKB518 Wins U.S. FDA IND Clearance
  • 4/22/2025China Approves New Indication of Opdivo for NSCLC
  • 4/22/2025AZ's Ultomiris for Generalized Myasthenia Gravis in China
  • 4/22/2025China Seeks Feedback on ICH Draft Guideline M13B for Biowaivers of Add...
  • 4/22/2025Fosun Boosts Stake in Henlius After Failed Privatization Attempt
  • 4/22/2025Fujifilm Capitalizes on U.S.-China Tensions with $3B Biopharma Deal
  • 4/22/2025Carbogen Amcis Secures Chinese Drug Manufacturing License
  • 4/19/2025HighTide's HTD1801 Meets Goals in Two Phase 3 Diabetes Trials
  • 4/19/2025China Approves AstraZeneca's Truqap for Advanced HR+/HER2– Breast Can...
  • 4/19/2025Akeso's Ebdarokimab Approved in China as First Domestic IL-12/IL-23 An...
  • 4/19/2025Haleon Achieves Full Ownership of Tianjin SmithKline JV
  • 4/19/2025China Issues New Guidelines to Streamline Mainland Registration for Or...
  • 4/18/2025VelaVigo and Ollin Biosciences Ink ex-Greater China Licensing Deal for...
  • 4/18/2025WuXi Biologics Completes 15,000L PPQ at Hangzhou Site
  • 4/18/2025Chinese drugmakers weigh options as US mulls pharma tariffs (KrAsia)
  • 4/17/2025This Pharma Company Is Betting Big On A Chinese Ozempic Rival (Forbes)
  • 4/17/2025Interpretation of the Anti-Monopoly Guidelines for Pharmaceutical Sect...
  • 4/17/2025BMS Launches Head-to-Head Phase 1 Trial for SystImmune-Licensed EGFR/H...
  • 4/17/2025DualityBio Raises $211M in Hong Kong IPO
  • 4/17/2025InnoCare's Zurletrectinib NDA Accepted by China's NMPA for NTRK Fusion...
  • 4/17/2025Eli Lilly's Mirikizumab Advances in China with New Indication Filing
  • 4/17/2025Akeso Advances Second ADC into Clinical Trials with TROP2/Nectin-4 Bis...
  • 4/17/2025Sanofi Secures Global Rights to AI-Discovered BsAb in $1.8B+ Deal with...
  • 4/17/2025Hengrui Advances CD79b-Targeted ADC SHR-A1912 into Phase 3 Trial for R...
  • 4/17/2025Latticon Pioneers China's First Pipeline-Backed Financing Deal
  • 4/17/2025Eddingpharm to Take Over Genor in HKEX's First 18A Reverse Merger
  • 4/17/2025WuXi AppTec Cashes Out of WuXi XDC as U.S. Tariff Threats Mount
  • 4/17/2025Pharma Giants Already Moving to Cut Reliance on China Amid Tariff Unce...
  • Page:3/764 Total number of articles:22892: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group